A Phase I Trial of Intratumoral Administration of CCL21-gene Modified Dendritic Cell (DC) Combined With Intravenous Pembrolizumab for Advanced NSCLC

Investigator(s):
Steven M. Dubinett, M.D.;
Organization: 
UCLA
NCT Number: 
Disease Name: 
Lung Cancer
Disease Category: 
Trial Phases: 
Phase 1
Trial Status: 
Recruiting
Steven M. Dubinett, M.D.
Steven M. Dubinett, M.D.
Trial Contact: 

Lia Etheridge 
(310) 825-7174 
letheridge@mednet.ucla.edu